ATR and neoplasm: Taken together, our study defines the POLD1R689W variant as target for ATR pathway inhibition and thereby illustrates the emerging role of tumor-specific alterations in polymerases39–43 along with the need of their comprehensive identification and functional characterization in suitable model systems to aid the development of novel and rational approaches towards improved tumor therapy44.